Market Capitalization of Cohance Lifesciences (COHANCE)
As of Sept. 18, 2026, Cohance Lifesciences (COHANCE) market capitalisation is ₹16205.54 Cr ($1.80B), with 37.00 Cr shares outstanding at a current price of ₹438.00 on NSE, ranking 420 out of 5367 companies by market cap in our screener. Cohance Lifesciences operates in the Healthcare sector and is classified as a Mid Cap stock. For live price, earnings and the complete company profile, see COHANCE stock price BSE.
Market Cap History of Cohance Lifesciences (Last 10 Years)
COHANCE market capitalisation from year-end NSE closing prices over the last 10 years. View COHANCE 52-week chart for the annual high/low range and current price position.
End of Year Market Cap History — Cohance Lifesciences
COHANCE year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Explore Cohance Lifesciences intrinsic worth to estimate fundamental worth using multiple valuation models.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹16205.54 Cr
$1.80B USD
|
₹438.00 | NSE | -17.14% |
| 2025 |
₹19557.64 Cr
$2.17B USD
|
₹528.60 | NSE | -53.58% |
| 2024 |
₹42132.55 Cr
$4.68B USD
|
₹1138.75 | NSE | +57.55% |
| 2023 |
₹26742.84 Cr
$2.97B USD
|
₹722.80 | NSE | +46.05% |
| 2022 |
₹18310.78 Cr
$2.03B USD
|
₹494.90 | NSE | +0.33% |
| 2021 |
₹18249.73 Cr
$2.03B USD
|
₹493.25 | NSE | +9.05% |
| 2020 |
₹16734.62 Cr
$1.86B USD
|
₹452.30 | NSE | +150666.67% |
| 2015 |
₹11.10 Cr
$1.23M USD
|
₹0.30 | NSE | - |